Evaluation of the Cardiovascular Risk in Patients with Biliary Stones; a Descriptive Cross-Sectional Study
Gastroenterology and Hepatology from Bed to Bench,
Vol. 11 No. Supplement 1 (2018),
11 December 2018
,
Page s14-s19
https://doi.org/10.22037/ghfbb.v0i0.1471
Abstract
Aim: the aim of this study was evaluating the risk of cardiovascular disease in patients with gallstones.
Background: Gallstones is the most common Biliary System disorder which its prevalence is increasing. On other hand, cardiovascular disease is the most common cause of mortality in the world. The causes and risk factors of cardiovascular diseases and gallstones are in common.
Methods: In this descriptive cross-sectional study, patient with gallstones who hospitalized in Taleghani Hospital of Shahid Beheshti University of medical sciences or referred to its clinics in 2017, shared their demographic information and their underlying diseases with us. In addition, more data was collected with clinical examination, blood test, echocardiography and ultrasonography. Data was analyzed by SPSS vs21 software. In addition, online software was used for calculating Framingham and ASCVD risk score for cardiovascular diseases.
Results: 105 patients with gallstones and 105 healthy people participated in this study. There was no significant difference between these two groups for existence of main risk factors, but the average amount of ALT, AST, and ALP enzymes in patients with gallstones were significantly more than the control group (P value<0.05). The average amount of Framingham score was not significantly different between these two groups and the average score of ASCVD was statistically lower in our case group.
Conclusion: The risk of cardiovascular disease in patients with gallstones is not significantly more than the general population.
Keywords: Cardiovascular disease, Gallstones, Risk factors.
(Please cite as: Seddighi SH, Ghidari ME, Sadeghi A, Shahrbaf AM, Mahmanzar MA, Saadati S, et al. Evaluation of the cardiovascular risk in patients with biliary stones; a descriptive cross-sectional study. Gastroenterol Hepatol Bed Bench 2018;11(Suppl. 1):S14-S19).
- Cardiovascular disease
- Gallstones
- Risk factors.
How to Cite
References
Festi D, Sottili S, Colecchia A, Attili A, Mazzella G, Roda E, et al. Clinical manifestations of gallstone disease: evidence from the multicenter Italian study on cholelithiasis (MICOL). Hepatology 1999;30:839-46.
Lammert F, Sauerbruch T. Mechanisms of disease: the genetic epidemiology of gallbladder stones. Nat Clin Pract Gastroenterol Hepatol 2005;2:423.
Völzke H, Baumeister SE, Alte D, Hoffmann W, Schwahn C, Simon P, et al. Independent risk factors for gallstone formation in a region with high cholelithiasis prevalence. Digestion 2005;71:97-105.
Sandler RS, Everhart JE, Donowitz M, Adams E, Cronin K, Goodman C, et al. The burden of selected digestive diseases in the United States. Gastroenterology 2002;122:1500-11.
Nazemalhosseini Mojarad E, Farahani RK, Haghighi MM, Aghdaei HA, Kuppen PJ, Zali MR. Clinical implications of BRAF mutation test in colorectal cancer. Gastroenterol Hepatol Bed Bench. 2013;6:6-13.
Schafmayer C, Hartleb J, Tepel J, Albers S, Freitag S, Völzke H, et al. Predictors of gallstone composition in 1025 symptomatic gallstones from Northern Germany. BMC gastroenterol 2006;6:36.
Rostami Nejad M, Ishaq S, Al Dulaimi D, Zali MR, Rostami K. The role of infectious mediators and gut microbiome in the pathogenesis of celiac disease. Arch Iran Med. 2015;18:244-49.
Agrawal S, Jonnalagadda S. Gallstones, from gallbladder to gut: management options for diverse complications. Postgrad Med 2000;108:143-53.
Yusuf S, Bosch J, Dagenais G, Zhu J, Xavier D, Liu L, et al. Cholesterol lowering in intermediate-risk persons without cardiovascular disease. N Engl J Med 2016;374:2021-31.
Forouzanfar M, Alexander L, Anderson H, Bachman V, Biryukov S, Brauer M, et al. GBD 2013 Risk Factors Collaborators. Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 2015;386:2287-323.
Lilly LS, Braunwald E. Braunwald's heart disease: a textbook of cardiovascular medicine: Elsevier Health Sciences;2012.
Hariri N, Nasseri E, Houshiar-Rad A, Zayeri F, Bondarianzadeh D. Association between alternative healthy eating index and 10-year risk of cardiovascular diseases in male-employees in the public sector in Tehran, 1391. Iranian Journal of Nutrition Sciences & Food Technology. 2013;8:41-50.
Méndez-Sánchez N, Bahena-Aponte J, Chávez-Tapia NC, Motola-Kuba D, Sánchez-Lara K, Ponciano-Radríguez G, et al. Strong association between gallstones and cardiovascular disease. Am J Gastroenterol 2005;100:827.
Ruhl CE, Everhart JE. Gallstone disease is associated with increased mortality in the United States. Gastroenterology 2011;140:508-16.
Chavez-Tapia NC, Mac Kinney-Novelo I, Sifuentes-Rentería SE, Torres-Zavala M, Castro-Gastelum G, Sánchez-Lara K, et al. Association between cholecystectomy for gallstone disease and risk factors for cardiovascular disease. Ann Hepatol 2012;11:85-9.
Portincasa P, Moschetta A, Palasciano G. Cholesterol gallstone disease. Lancet 2006;368:230-9.
Scott J. Pathophysiology and biochemistry of cardiovascular disease. Curr Opin Genet Dev 2004;14:271-9.
Eaton CB. Traditional and emerging risk factors for cardiovascular disease. Prim Care 2005;32:963-76.
Taghipour N, Aghdaei HA, Haghighi A, Mossafa N, Tabaei SJ, Rostami-Nejad M. Potential treatment of inflammatory bowel disease: a review of helminths therapy. Gastroenterol Hepatol Bed Bench. 2014;7:9-16.
Mendez-Sanchez N, Zamora-Valdes D, Flores-Rangel JA, Perez-Sosa JA, Vasquez-Fernandez F, Lezama-Mora JI, et al. Gallstones are associated with carotid atherosclerosis. Liver Int. 2008;28:402-6.
Ata N, Kucukazman M, Yavuz B, Bulus H, Dal K, Ertugrul DT, et al. The metabolic syndrome is associated with complicated gallstone disease. Can J Gastroenterol 2011;25:274-6.
Kannel WB. The Framingham study: an epidemiological investigation of cardiovascular disease. Section 34. Some risk factors related to the annual incidence of cardiovascular disease and death using pooled repeated biennial measurements. Framingham Heart Study, 30 year follow up. 1987.
Eesteghamati A, Gouya M, Keshtkar A, Najafi L, Zali MR, Sanaei M, et al. Sentinel hospital-based surveillance of rotavirus diarrhea in iran. J Infect Dis. 2009;200:S244-47.
Expert Panel on Detection E. Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). Jama 2001;285:2486.
Ray KK, Kastelein JJ, Matthijs Boekholdt S, Nicholls SJ, Khaw K-T, Ballantyne CM, et al. The ACC/AHA 2013 guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular disease risk in adults: the good the bad and the uncertain: a comparison with ESC/EAS guidelines for the management of dyslipidaemias 2011. Eur Heart J 2014;35:960-8.
Olaiya MT, Chiou H-Y, Jeng J-S, Lien L-M, Hsieh F-I. Significantly increased risk of cardiovascular disease among patients with gallstone disease: a population-based cohort study. PLoS One 2013;8:e76448.
Wirth J, Giuseppe Rd, Wientzek A, Katzke VA, Kloss M, Kaaks R, et al. Presence of gallstones and the risk of cardiovascular diseases: The EPIC-Germany cohort study. Eur J Prev Cardiol cardiology 2015;22:326-34.
Lv J, Qi L, Yu C, Guo Y, Bian Z, Chen Y, et al. Gallstone disease and the risk of ischemic heart disease. Arterioscler Thromb Vasc Biol 2015;35:2232-7.
Upala S, Sanguankeo A, Jaruvongvanich V. Gallstone Disease and the Risk of Cardiovascular Disease: A Systematic Review and Meta-Analysis of Observational Studies. Scand J Surg 2017;106:21-7.
Fan LL, Chen BH, Dai ZJ. The relation between gallstone disease and cardiovascular disease. Sci Rep 2017;7:15104.
- Abstract Viewed: 130 times
- PDF Downloaded: 140 times